-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Capricor Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Capricor Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$13M, a 89.5% decline year-over-year.
- Capricor Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$36.1M, a 17.1% decline year-over-year.
- Capricor Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$24.1M, a 18.9% increase from 2022.
- Capricor Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$29.7M, a 41.8% decline from 2021.
- Capricor Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$20.9M, a 52.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)